Delapril

Delapril

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C09AA12 (WHO)
Identifiers
IUPAC name 2-[2,3-dihydro-1H-inden-2-yl-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic acid
CAS Number	83435-66-9 Y
PubChem CID	5362116
ChemSpider	4514931 N
UNII	W77UAL9THI
KEGG	D07781 Y
ChEMBL	ChEMBL2106126 N
CompTox Dashboard (EPA)	DTXSID101016742
Chemical and physical data
Formula	C26H32N2O5
Molar mass	452.551 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OCC)[C@@H](N[C@H](C(=O)N(CC(=O)O)C2Cc1ccccc1C2)C)CCc3ccccc3
InChI InChI=1S/C26H32N2O5/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30)/t18-,23-/m0/s1 N Key:WOUOLAUOZXOLJQ-MBSDFSHPSA-N N
NY (what is this?)  (verify)

Delapril (INN, also known as alindapril) is an ACE inhibitor used as an antihypertensive drug¹ in some European and Asian countries but not in America.² It is taken orally, available in 15 mg and 30 mg tablets.³

Delapril is a prodrug; it is converted into two active metabolites, 5-hydroxy delapril diacid and delapril diacid. These metabolites bind completely to and inhibit angiotensin-converting enzyme (ACE), hence blocking angiotensin I to angiotensin II conversion. The resulting vasodilation prevents the vasoconstrictive effects of angiotensin II. Angiotensin II-induced aldosterone secretion by the adrenal cortex is also decreased by Delapril, leading to increases in excretion of sodium and therefore increases water outflow.⁴